Cargando…

Cabazitaxel-Loaded Nanoparticles Reduce the Invasiveness in Metastatic Prostate Cancer Cells: Beyond the Classical Taxane Function

Bone-metastatic prostate cancer symbolizes the beginning of the later stages of the disease. We designed a cabazitaxel-loaded, poly (lactic-co-glycolic acid) (PLGA) nanoparticle using an emulsion-diffusion-evaporation technique. Bis (sulfosuccinimidyl) suberate (BS3) was non-covalently inserted into...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lampe, Jana B., Desai, Priyanka P., Tripathi, Amit K., Sabnis, Nirupama A., Chen, Zhe, Ranjan, Amalendu P., Vishwanatha, Jamboor K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967362/ https://www.ncbi.nlm.nih.gov/pubmed/36839985 http://dx.doi.org/10.3390/pharmaceutics15020662

Ejemplares similares

Bone-targeted cabazitaxel nanoparticles for metastatic prostate cancer skeletal lesions and pain
por: Gdowski, Andrew S, et al.
Publicado: (2017)

Development of Biodegradable Nanocarriers Loaded with a Monoclonal Antibody
por: Gdowski, Andrew, et al.
Publicado: (2015)

Scale up, optimization and stability analysis of Curcumin C3 complex-loaded nanoparticles for cancer therapy
por: Ranjan, Amalendu P, et al.
Publicado: (2012)

Current concepts in bone metastasis, contemporary therapeutic strategies and ongoing clinical trials
por: Gdowski, Andrew S., et al.
Publicado: (2017)

Mitigating prolonged QT interval in cancer nanodrug development for accelerated clinical translation
por: Ranjan, Amalendu P, et al.
Publicado: (2013)

Evidence-based approaches to reduce cancer health disparities: Discover, develop, deliver, and disseminate
por: Desai, Priyanka P., et al.
Publicado: (2018)

Combination of Small Extracellular Vesicle-Derived Annexin A2 Protein and mRNA as a Potential Predictive Biomarker for Chemotherapy Responsiveness in Aggressive Triple-Negative Breast Cancer
por: Desai, Priyanka P., et al.
Publicado: (2022)

Optimization and scale up of microfluidic nanolipomer production method for preclinical and potential clinical trials
por: Gdowski, Andrew, et al.
Publicado: (2018)

Role of Anti-Cancer Peptides as Immunomodulatory Agents: Potential and Design Strategy
por: Tripathi, Amit Kumar, et al.
Publicado: (2022)

Novel Use of Hypoxia-Inducible Polymerizable Protein to Augment Chemotherapy for Pancreatic Cancer
por: Gdowski, Andrew, et al.
Publicado: (2022)

Cabazitaxel: A novel taxane for metastatic castration-resistant prostate cancer-current implications and future prospects
por: Abidi, Afroz
Publicado: (2013)

Cabazitaxel-Loaded Nanocarriers for Cancer Therapy with Reduced Side Effects
por: Kommineni, Nagavendra, et al.
Publicado: (2019)

Preclinical profile of cabazitaxel
por: Vrignaud, Patricia, et al.
Publicado: (2014)

Prognostic impact of AnxA1 and AnxA2 gene expression in triple-negative breast cancer
por: Gibbs, Lee D., et al.
Publicado: (2017)

CRISPR deletion of MIEN1 in breast cancer cells
por: Van Treuren, Timothy, et al.
Publicado: (2018)

Preparation and Evaluation of Cabazitaxel-Loaded Bovine Serum Albumin Nanoparticles for Prostate Cancer
por: Wan, Zhong, et al.
Publicado: (2020)

Oncogenic activation in prostate cancer progression and metastasis: Molecular insights and future challenges
por: Dasgupta, Subhamoy, et al.
Publicado: (2012)

Antiangiogenic mechanisms and factors in breast cancer treatment
por: Castañeda-Gill, Jessica M., et al.
Publicado: (2016)

Absence of annexin I expression in B-cell non-Hodgkin's lymphomas and cell lines
por: Vishwanatha, Jamboor K, et al.
Publicado: (2004)

Beyond taxanes: the next generation of microtubule-targeting agents
por: Cortes, Javier, et al.
Publicado: (2011)

Effect of down-regulation of aquaporins in human corneal endothelial and epithelial cell lines
por: Shankardas, Jwalitha, et al.
Publicado: (2010)

Intersection of Smoking, Human immunodeficiency virus/acquired immunodeficiency syndrome and Cancer: Proceedings of the 8(th) Annual Texas Conference on Health Disparities
por: Rajendiran, Smrithi, et al.
Publicado: (2013)

Phase 2 study of cabazitaxel as second-line treatment in patients with HER2-negative metastatic breast cancer previously treated with taxanes—a Hellenic Cooperative Oncology Group (HeCOG) Trial
por: Koutras, Angelos, et al.
Publicado: (2020)

Cabazitaxel versus docetaxel for treatment of metastatic castrate refractory prostate cancer
por: James, Nicholas D., et al.
Publicado: (2022)

Cabazitaxel-loaded human serum albumin nanoparticles as a therapeutic agent against prostate cancer
por: Qu, Na, et al.
Publicado: (2016)

Reduction-Responsive Stearyl Alcohol-Cabazitaxel Prodrug Nanoassemblies for Cancer Chemotherapy
por: Liu, Yuting, et al.
Publicado: (2023)

Feasibility of cabazitaxel in octogenarian prostate cancer patients
por: Tralongo, Paolo, et al.
Publicado: (2023)

Clinical Development of Cabazitaxel for the Treatment of Castration-Resistant Prostate Cancer
por: Tsao, Che-Kai, et al.
Publicado: (2011)

Active targeting of orthotopic glioma using biomimetic liposomes co-loaded elemene and cabazitaxel modified by transferritin
por: Li, Jie, et al.
Publicado: (2021)

Breast cancer disparities: Frontline strategies, proceedings of the 7(th) annual texas conference on health disparities
por: Kpetemey, Marilyne, et al.
Publicado: (2012)

MIEN1 drives breast tumor cell migration by regulating cytoskeletal-focal adhesion dynamics
por: Kpetemey, Marilyne, et al.
Publicado: (2016)

Leading Predictors of COVID-19-Related Poor Mental Health in Adult Asian Indians: An Application of Extreme Gradient Boosting and Shapley Additive Explanations
por: Ikram, Mohammad, et al.
Publicado: (2022)

Nuclear annexin II negatively regulates growth of LNCaP cells and substitution of ser 11 and 25 to glu prevents nucleo-cytoplasmic shuttling of annexin II
por: Liu, Jie, et al.
Publicado: (2003)

Casodex treatment induces hypoxia-related gene expression in the LNCaP prostate cancer progression model
por: Rothermund, Christy A, et al.
Publicado: (2005)

Critical appraisal of cabazitaxel in the management of advanced prostate cancer
por: Pal, Sumanta Kumar, et al.
Publicado: (2010)

Population pharmacokinetics of cabazitaxel in patients with advanced solid tumors
por: Ferron, Géraldine M., et al.
Publicado: (2013)

Adjuvant therapy of endometrial cancer: “taxane or not taxane, this is the question”
por: Lorusso, Vito, et al.
Publicado: (2019)

Taxane-induced acute interstitial pneumonitis in patients with breast cancer and outcome of taxane rechallenge
por: Anoop, T M, et al.
Publicado: (2022)

Cabazitaxel for Metastatic Castration-Resistant Prostate Cancer: Retrospective Data Analysis from an Indian Centre
por: Noronha, Vanita, et al.
Publicado: (2016)

Continued Androgen Signalling Inhibition improves Cabazitaxel Efficacy in Prostate Cancer
por: Mout, Lisanne, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7rb1442p5ottvc010f7rsl9ne0